This document provides a curriculum vitae for Urmi Roy, including her contact information, education history, research interests, publications, presentations, and affiliations. She received her Ph.D. from the Indian Institute of Chemical Biology in 2002 and is currently an Adjunct Research Associate Professor at Clarkson University. Her research focuses on structural biology, protein chemistry, and computational modeling to explore applications in drug discovery. She has over 20 publications and has presented her work at several conferences.
Potentials of 3D models in anticancer drug screeningAnjali R.
A short presentation about the differences between 2D and 3D culture models, why researchers are moving toward 3D models in anticancer drug screening, the methods used in doing so and a recent case study of 3D tumour model being used for drug screening.
Thesis Proposal, as presented for dissertation proposal defenseHeather Piwowar
The slides I presented for my PhD proposal defense for my project, "Foundational studies for measuring the impact, prevalence, and patterns of publicly sharing biomedical research data." Dept of Biomedical Informatics, University of Pittsburgh.
Bioinformatics in the Clinical Pipeline: Contribution in Genomic Medicineiosrjce
In this review report we like to focus on the new challenges in methodology of modern biology be
used in medical science. Today human health is a primary issue to cure disease, undoubtedly the answer to this
is bioinformatics or (In-silco) tools has change the concept of treating patients to understand the need of
genomic medicine in use. Those with new modes of action in clinical treatment, is a major health concern in
medical science. On global prospective scientific role in constructing new ideas to remediate health care to
treat disease exciting in nature is challenging task. So awareness needs to accelerate store clinical datasets for
scientific represents to design genomic drugs. This new outline will drive the medical to discover public data
and create a cognitive approach to use technology cheaper at cost effective mode.
EFFICACY OF NON-NEGATIVE MATRIX FACTORIZATION FOR FEATURE SELECTION IN CANCER...IJDKP
Over the past few years, there has been a considerable spread of microarray technology in many biological patterns, particularly in those pertaining to cancer diseases like leukemia, prostate, colon cancer, etc. The primary bottleneck that one experiences in the proper understanding of such datasets lies in their dimensionality, and thus for an efficient and effective means of studying the same, a reduction in their dimension to a large extent is deemed necessary. This study is a bid to suggesting different algorithms and approaches for the reduction of dimensionality of such microarray datasets.This study exploits the matrix-like structure of such microarray data and uses a popular technique called Non-Negative Matrix Factorization (NMF) to reduce the dimensionality, primarily in the field of biological data. Classification accuracies are then compared for these algorithms.This technique gives an accuracy of 98%.
EFFICACY OF NON-NEGATIVE MATRIX FACTORIZATION FOR FEATURE SELECTION IN CANCER...IJDKP
Over the past few years, there has been a considerable spread of microarray technology in many
biological patterns, particularly in those pertaining to cancer diseases like leukemia, prostate, colon
cancer, etc. The primary bottleneck that one experiences in the proper understanding of such datasets lies
in their dimensionality, and thus for an efficient and effective means of studying the same, a reduction in
their dimension to a large extent is deemed necessary. This study is a bid to suggesting different algorithms
and approaches for the reduction of dimensionality of such microarray datasets.This study exploits the
matrix-like structure of such microarray data and uses a popular technique called Non-Negative Matrix
Factorization (NMF) to reduce the dimensionality, primarily in the field of biological data. Classification
accuracies are then compared for these algorithms.This technique gives an accuracy of 98%
Potentials of 3D models in anticancer drug screeningAnjali R.
A short presentation about the differences between 2D and 3D culture models, why researchers are moving toward 3D models in anticancer drug screening, the methods used in doing so and a recent case study of 3D tumour model being used for drug screening.
Thesis Proposal, as presented for dissertation proposal defenseHeather Piwowar
The slides I presented for my PhD proposal defense for my project, "Foundational studies for measuring the impact, prevalence, and patterns of publicly sharing biomedical research data." Dept of Biomedical Informatics, University of Pittsburgh.
Bioinformatics in the Clinical Pipeline: Contribution in Genomic Medicineiosrjce
In this review report we like to focus on the new challenges in methodology of modern biology be
used in medical science. Today human health is a primary issue to cure disease, undoubtedly the answer to this
is bioinformatics or (In-silco) tools has change the concept of treating patients to understand the need of
genomic medicine in use. Those with new modes of action in clinical treatment, is a major health concern in
medical science. On global prospective scientific role in constructing new ideas to remediate health care to
treat disease exciting in nature is challenging task. So awareness needs to accelerate store clinical datasets for
scientific represents to design genomic drugs. This new outline will drive the medical to discover public data
and create a cognitive approach to use technology cheaper at cost effective mode.
EFFICACY OF NON-NEGATIVE MATRIX FACTORIZATION FOR FEATURE SELECTION IN CANCER...IJDKP
Over the past few years, there has been a considerable spread of microarray technology in many biological patterns, particularly in those pertaining to cancer diseases like leukemia, prostate, colon cancer, etc. The primary bottleneck that one experiences in the proper understanding of such datasets lies in their dimensionality, and thus for an efficient and effective means of studying the same, a reduction in their dimension to a large extent is deemed necessary. This study is a bid to suggesting different algorithms and approaches for the reduction of dimensionality of such microarray datasets.This study exploits the matrix-like structure of such microarray data and uses a popular technique called Non-Negative Matrix Factorization (NMF) to reduce the dimensionality, primarily in the field of biological data. Classification accuracies are then compared for these algorithms.This technique gives an accuracy of 98%.
EFFICACY OF NON-NEGATIVE MATRIX FACTORIZATION FOR FEATURE SELECTION IN CANCER...IJDKP
Over the past few years, there has been a considerable spread of microarray technology in many
biological patterns, particularly in those pertaining to cancer diseases like leukemia, prostate, colon
cancer, etc. The primary bottleneck that one experiences in the proper understanding of such datasets lies
in their dimensionality, and thus for an efficient and effective means of studying the same, a reduction in
their dimension to a large extent is deemed necessary. This study is a bid to suggesting different algorithms
and approaches for the reduction of dimensionality of such microarray datasets.This study exploits the
matrix-like structure of such microarray data and uses a popular technique called Non-Negative Matrix
Factorization (NMF) to reduce the dimensionality, primarily in the field of biological data. Classification
accuracies are then compared for these algorithms.This technique gives an accuracy of 98%
Top downloaded article in academia 2020 - International Journal of Computatio...ijcsity
International Journal of Computational Science and Information Technology (IJCSITY) focuses on Complex systems, information and computation using mathematics and engineering techniques. This is an open access peer-reviewed journal will act as a major forum for the presentation of innovative ideas, approaches, developments, and research projects in the area of Computation theory and applications. It will also serve to facilitate the exchange of information between researchers and industry professionals to discuss the latest issues and advancement in the area of advanced Computation and its applications.
Accessing and Sharing Electronic Personal Health Data.Maria Karampela
An increasing attention has been given to personal health data (PHD) research over the last years. The rise of researchers’ interest could be attributed to the increasing amount of PHD that are stored across various databases, as a result of individuals’ rapidly- evolving digital life. Accessing and sharing PHD is essential to create personalized health services and to involve patients in the design process of these services. This paper conducts a survey of literature to present an overview of literature about accessing and sharing of PHD. This study aims to identify limitations in research and propose future directions. Sixteen studies were selected from various bibliographic databases and were classified according to three criteria: research type, empirical type and contribution type. The results provide a preliminary review with respect to access and sharing of PHD, addressing a need for more research about PHD accessibility and for solution proposals for both topics.
Accessing and Sharing Electronic Personal Health DataSofia Ouhbi
Accessing and sharing PHD is essential to create personalized health services and to involve patients in the design process of these services. This paper conducts a survey of literature to present an overview of literature about accessing and sharing of PHD. This study aims to identify limitations in research and propose future directions.
With the DNA sequences of more than 90 genomes completed, as well as a draft sequence of the human genome, a major challenge in modern biology is to understand the expression, function, and regulation of the entire set of proteins encoded by an organism—the aims of the new field of proteomics. This information will be invaluable for understanding how complex biological processes occur at a molecular level, how they differ in various cell types, and how they are altered in disease states. The term proteomics describes the study and characterization of a complete set of proteins present in a cell, organ, or organism at a given time.
In general, proteomic approaches can be used (a) for proteome profiling, (b) for comparative expression analysis of two or more protein samples, (c) for the localization and identification of posttranslational modifications, and (d) for the study of protein-protein interactions. The human genome harbours 26000–31000 protein-encoding genes; whereas the total number of human protein products, including splice variants and essential posttranslational modifications (PTMs), has been estimated to be close to one million. It is evident that most of the functional information on the genes resides in the proteome, which is the sum of multiple dynamic processes that include protein phosphorylation, protein trafficking, localization, and protein-protein interactions. Moreover, the proteomes of mammalian cells, tissues, and body fluids are complex and display a wide dynamic range of proteins concentration one cell can contain between one and more than 100000 copies of a single protein.
A rapidly emerging set of key technologies is making it possible to identify large numbers of proteins in a mixture or complex, to map their interactions in a cellular context, and to analyze their biological activities. Mass spectrometry has evolved into a versatile tool for examining the simultaneous expression of more than 1000 proteins and the identification and mapping of posttranslational modifications. High-throughput methods performed in an array format have enabled large-scale projects for the characterization of protein localization, protein-protein interactions, and the biochemical analysis of protein function. Finally, the plethora of data generated in the last few years has led to approaches for the integration of diverse data sets that greatly enhance our understanding of both individual protein function and elaborate biological processes.
Dr.Rahul Hajare is a post doctoral student of Renowned Scientist Respected Dr. R S. Paranjape Retired Director and Scientist ‘G’ National AIDS Research Institute India. He achieved his training at the National AIDS Research Institute, the reputed and primer HIV research institute in India. Dr. Hajare is board certified by Director-in-Charge, National AIDS Research Institute, the Secretory Board of Management KLE Society Belagavi, Registrar Vinayaka Mission’s Research Foundation, Aarti Drugs Limited and Shikshan Vikas Mandal. Dr Hajare won World Academic Championship-2017 in Pharmacy (Antiretroviral Therapy) and certified as Fellow, Directorate of Pharmacy, IASR (Lifetime Membership).
The Art Pastor's Guide to Sabbath | Steve ThomasonSteve Thomason
What is the purpose of the Sabbath Law in the Torah. It is interesting to compare how the context of the law shifts from Exodus to Deuteronomy. Who gets to rest, and why?
How to Make a Field invisible in Odoo 17Celine George
It is possible to hide or invisible some fields in odoo. Commonly using “invisible” attribute in the field definition to invisible the fields. This slide will show how to make a field invisible in odoo 17.
The Indian economy is classified into different sectors to simplify the analysis and understanding of economic activities. For Class 10, it's essential to grasp the sectors of the Indian economy, understand their characteristics, and recognize their importance. This guide will provide detailed notes on the Sectors of the Indian Economy Class 10, using specific long-tail keywords to enhance comprehension.
For more information, visit-www.vavaclasses.com
The French Revolution, which began in 1789, was a period of radical social and political upheaval in France. It marked the decline of absolute monarchies, the rise of secular and democratic republics, and the eventual rise of Napoleon Bonaparte. This revolutionary period is crucial in understanding the transition from feudalism to modernity in Europe.
For more information, visit-www.vavaclasses.com
The Roman Empire A Historical Colossus.pdfkaushalkr1407
The Roman Empire, a vast and enduring power, stands as one of history's most remarkable civilizations, leaving an indelible imprint on the world. It emerged from the Roman Republic, transitioning into an imperial powerhouse under the leadership of Augustus Caesar in 27 BCE. This transformation marked the beginning of an era defined by unprecedented territorial expansion, architectural marvels, and profound cultural influence.
The empire's roots lie in the city of Rome, founded, according to legend, by Romulus in 753 BCE. Over centuries, Rome evolved from a small settlement to a formidable republic, characterized by a complex political system with elected officials and checks on power. However, internal strife, class conflicts, and military ambitions paved the way for the end of the Republic. Julius Caesar’s dictatorship and subsequent assassination in 44 BCE created a power vacuum, leading to a civil war. Octavian, later Augustus, emerged victorious, heralding the Roman Empire’s birth.
Under Augustus, the empire experienced the Pax Romana, a 200-year period of relative peace and stability. Augustus reformed the military, established efficient administrative systems, and initiated grand construction projects. The empire's borders expanded, encompassing territories from Britain to Egypt and from Spain to the Euphrates. Roman legions, renowned for their discipline and engineering prowess, secured and maintained these vast territories, building roads, fortifications, and cities that facilitated control and integration.
The Roman Empire’s society was hierarchical, with a rigid class system. At the top were the patricians, wealthy elites who held significant political power. Below them were the plebeians, free citizens with limited political influence, and the vast numbers of slaves who formed the backbone of the economy. The family unit was central, governed by the paterfamilias, the male head who held absolute authority.
Culturally, the Romans were eclectic, absorbing and adapting elements from the civilizations they encountered, particularly the Greeks. Roman art, literature, and philosophy reflected this synthesis, creating a rich cultural tapestry. Latin, the Roman language, became the lingua franca of the Western world, influencing numerous modern languages.
Roman architecture and engineering achievements were monumental. They perfected the arch, vault, and dome, constructing enduring structures like the Colosseum, Pantheon, and aqueducts. These engineering marvels not only showcased Roman ingenuity but also served practical purposes, from public entertainment to water supply.
Synthetic Fiber Construction in lab .pptxPavel ( NSTU)
Synthetic fiber production is a fascinating and complex field that blends chemistry, engineering, and environmental science. By understanding these aspects, students can gain a comprehensive view of synthetic fiber production, its impact on society and the environment, and the potential for future innovations. Synthetic fibers play a crucial role in modern society, impacting various aspects of daily life, industry, and the environment. ynthetic fibers are integral to modern life, offering a range of benefits from cost-effectiveness and versatility to innovative applications and performance characteristics. While they pose environmental challenges, ongoing research and development aim to create more sustainable and eco-friendly alternatives. Understanding the importance of synthetic fibers helps in appreciating their role in the economy, industry, and daily life, while also emphasizing the need for sustainable practices and innovation.
1. Urmi ROY June 2020
_____________________________________________________________
Contact Information
Department of Chemistry & Biomolecular Science
Clarkson University, Potsdam, NY 13699-5820
E-mail: urmi@clarkson.edu
Web: https://people.clarkson.edu/~urmi/
ORCID ID: https://orcid.org/0000-0003-0928-0574
ResearchGate Profile
Google Scholar Citation
Education
Ph.D., Indian Institute of Chemical Biology, Jadavpur University, Calcutta, India (2002)
Specialization: Nuclear Medicine and Drug Design
Doctoral Thesis: Kit Formulation of Technetium-99m Cysteine For Myocardial Infarct
Imaging. Thesis Adviser: Late Dr. Some Nath Banerjee, Former Assistant Director &
Head, Department of Nuclear Medicine, Indian Institute of Chemical Biology, Calcutta,
India
M.Sc., Zoology, Calcutta University, India (1992)
Specialization: Advanced Cytology & Genetics
Standing: First Class (equivalent overall letter grade: A)
B.Sc., Zoology (Honors), with minors in Chemistry and Botany, Calcutta University,
India (1990). Standing: Second Class (equivalent overall letter grade: B+)
Present Affiliation
• Adjunct Research Associate Professor, Department of Chemistry & Biomolecular
Science, Clarkson University, Potsdam, NY 13699
Research Interests
My current research interest is in the field of Structural Biology, and I am particularly
interested in Protein Chemistry and Protein Modeling. My research focuses mostly on
the molecular interactions between ligands and receptors, and I am interested in exploring
their applications for innovative drug discovery. The specific aspects of my ongoing
research are:
2. Urmi Roy CV
2
• Modeling of Receptor Proteins
• Protein-Peptide/Protein-Protein Docking
• Identification of Ligand-Receptor Interactions at the Interface
• Solvation Effect (Explicit Solvation and Molecular Dynamics Simulation)
• Protein-Protein Interaction (PPI) Network: Identification of Functional Partners
for Potential Protein Receptor using PPI Network
• Structural Immunology (computational) and Immunoinformatics
• Educational Protein Modeling for Undergraduates
Recent Research Collaborations
Research experience in the areas of Biochemistry, Structural Biochemistry, Proteomics
and Protein Modeling in collaboration with research groups at Clarkson University.
Past Appointments
• Visiting Research Associate Professor, Department of Chemistry & Biomolecular
Science, Clarkson University, Potsdam, NY 13699 (2012-2013)
• Senior Research Fellow, Department of Nuclear Medicine, Indian Institute of
Chemical Biology, Calcutta, India (1995-1999)
• Junior Research Fellow, Dept of Nuclear Medicine, Indian Institute Of Chemical
Biology, Calcutta, India. (1993-1995)
Publications and Patent
23. U. Roy, Structural and Molecular Analyses of Functional Epitopes and Escape
Mutants in Japanese Encephalitis Virus Envelope Protein Domain III, Immunologic
Research, 68, 81-89 (2020). https://doi.org/10.1007/s12026-020-09130-y.
-This article has been included in “Nature Public Health Emergency Collection”
(Public Health Emergency COVID-19 Initiative).
22. U. Roy, 3D Modeling of Tumor Necrosis Factor Receptor and Tumor Necrosis
Factor-Bound Receptor Systems, Molecular Informatics, 38 (5), 1800011 (2019).
DOI: 10.1002/minf.201800011.
21. U. Roy, Structure and Function of an Inflammatory Cytokine, Interleukin-2,
Analyzed using the Bioinformatic Approach, The Protein Journal, 38, 525-536 (2019).
DOI: 10.1007/s10930-019-09833-8.
20. U. Roy, Structural Modeling of Tumor Necrosis Factor: A Protein of Immunological
Importance, Biotechnology and Applied Biochemistry, 64, 454-463 (2017).
DOI: 10.1002/bab.1523. This article has been selected as editor's choice and has also
been mentioned on the journal's cover page. The inaugural “In This Issue: Issue
Highlights” feature of this journal has mentioned this paper (p 453).
3. Urmi Roy CV
3
19. U. Roy, Structural Characterizations of the Fas Receptor and the Fas-Associated
Protein with Death Domain Interactions, The Protein Journal, 35, 51-60 (2016).
DOI:10.1007/s10930-015-9646-6
18. U. Roy, Structural Biology of Tumor Necrosis Factor Demonstrated for
Undergraduate Instruction by Computer Simulation, Biochemistry and Molecular Biology
Education, 44, 246–255 (2016). DOI 10.1002/bmb.20937.
Featured article in BAMBED May/June 2016.
17. Book Chapter: U. Roy, A. G. Woods, I. Sokolowska, C. C. Darie, Utility of
Computational Structural Biology in Mass Spectrometry, Chapter 6. Advancements of
Mass Spectrometry in Biomedical Research 806, 107-128 (2014) Eds. A. G. Woods & C.
C. Darie, Advances in Experimental Medicine and Biology Series. ISBN 978-3-319-
06067-5, Springer.
16. A. G. Ngounou Wetie, I. Sokolowska, A. G. Woods, U. Roy, K. Deinhardt, C. C.
Darie, Protein-protein interactions: switch from classical methods to proteomics and
bioinformatics-based approaches, Cellular and Molecular Life Sciences, 71 205-228
(2014). – Review.
15. U. Roy, A. G. Woods, I. Sokolowska, C. C. Darie, Structural investigation of HSP70-
HSP90 and HSP90-TDF interactions. Mod Chem Appl 2: 126 (2014).
14. U. Roy, A. G. Woods, I. Sokolowska, C. C. Darie, Structural Evaluation and
Analyses of Tumor Differentiation Factor. The Protein Journal, 32 512-518 (2013).
13. I. Sokolowska, A. G. Ngounou Wetie, U. Roy, A. G. Woods, and C. C. Darie, Mass
spectrometry Investigation of Glycosylation on the NXS/T Sites in Recombinant
Glycoproteins. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 1834
1474–1483 (2013).
12. A. G. Ngounou Wetie, I. Sokolowska, A. G. Woods, U. Roy, J. A. Loo, C. C. Darie,
Investigation of stable and transient protein-protein interactions: past, present and future,
Proteomics, 13, 538–557 (2013) –Review. Included in the Journal's Special Issue:
“REVIEWS 2013”.
Most Accessed Article in 8/2013, 9/2013, 10/2013 and 11/2012–10/2013.
11. I. Sokolowska, A. G. Woods, M. A. Gawinowicz, U. Roy, and C. C. Darie,
Characterization of Tumor Differentiation Factor (TDF) and its receptor (TDF-R),
Cellular and Molecular Life Sciences, 70, 2835-2848 (2013) –Review.
10. U. Roy, I. Sokolowska, A. G. Woods, C. C. Darie, Tumor differentiation factor
(TDF) and its receptor (TDF-R): is TDF-R an inducible complex with multiple docking
sites?, Mod Chem Appl 1 (3) (2013). Most Viewed Article.
4. Urmi Roy CV
4
9. U. Roy, I. Sokolowska, A. G. Woods, C. C. Darie, Structural investigation of Tumor
Differentiation Factor (TDF), Biotechnology and Applied Biochemistry, 59, 445-450
(2012). This article was selected for Editor's Choice: Nov/Dec 2012 - Jan/Feb 2013.
Most Accessed 1/2013–12/2013.
8. I. Sokolowska, A. G. Woods, M. A. Gawinowicz, U. Roy, and C.C. Darie,
Identification of a potential tumor differentiation factor receptor candidate in prostate
cancer cells, FEBS Journal, 279, 2579–2594 (2012).
7. I. Sokolowska, A. G. Woods, M. A. Gawinowicz, U. Roy, and C.C. Darie,
Identification of a potential tumor differentiation factor (TDF) receptor from steroid-
responsive and steroid-resistant breast cancer cells, The Journal of Biological Chemistry,
287, 1719-33 (2012).
6. U. Roy and L. A. Luck, Cysteine residues in heavy metal binding proteins: structural
insights and comparison with leucine binding protein, Journal of Chemistry and
Chemical Engineering, 5, 771-777 (2011).
5. M.C. Debnath, U. Roy, K.K. Halder, B.R. Sarkar, S. Sinha and S. Ganguly,
Technetium-99m cysteine; A novel radiopharmaceutical for detection of experimental
myocardial infarction in rats, Current Radiopharmaceuticals, 3, 290-296 (2010).
4. U. Roy and L. A. Luck, Molecular modeling of estrogen receptor using molecular
operating environment, Biochemistry and Molecular Biology Education. 35, 238-243.
(2007).
[This undergraduate educational paper was highlighted as an explicatory contemporary
paper on structural biochemistry published in BAMBED, RCSB PDB Newsletter, Summer
2008, Number 38, Education Corner].
3. U. Roy, M. Chatterjee Debnath, K. Sanyal, M. K. Das, S. Banerjee , Role of protecting
groups in the preparation of thiolate complexes of technetium -99m using cysteine as a
model, Journal of Labelled Compounds and Radiopharmaceuticals 49, 10, 835-847
(2006).
2. U. Mitra, S.Mukherjee and S. Banerjee, Sulpher to nitrogen benzoyl transfer in
protected aminothiol ligand, Indian Journal of Nuclear Medicine, Issue 1, January 1995
[Published under my maiden name].
1. S. Banerjee, U. Mitra, M. Chatterjee, A process for the preparation of technetium
chelates with thiolate protected ligands useful for nuclear imaging study, Indian patent
filed number 613/DEL/2000 [Patent filed under my maiden name].
h-index: 10 (Source: Google scholar)
5. Urmi Roy CV
5
Recent Presentations and Posters
16. U. Roy, Structure and Function of an Inflammatory Cytokine, Interleukin-2 and its
Implications in Drug Design, Poster presented at 32nd
Center for Advanced Materials
Processing Annual Technical Meeting, May 21 2019, Syracuse, NY.
15. U. Roy, Modeling and Structure based Immunoinformatic Analysis of the Fas
Receptor and the Fas-Associated Protein with Death Domain, Poster presented at 29th
Center for Advanced Materials Processing Annual Technical Meeting, May 19 2016,
Canandaigua, NY.
14. U. Roy, Insight into the Structure of Tumor Necrosis Factor: A Protein of
Immunological Importance, Poster presented at 28th
Center for Advanced Materials
Processing Annual Technical Meeting, May 21 2015, Canandaigua, NY.
13. A. G. Ngounou Wetie, I. Sokolowska, U. Roy, A. G. Woods, and C. C. Darie, Mass
Spectrometry Analysis of NXS/T Glycosylation Sites in Recombinant Glycoproteins -
Poster presented at 2014 Eastern Analytical Symposium & Exposition (EAS), November
2014, Somerset NJ.
12. Guest Lecturer for Biochemistry course (BY450/BY650/CM460/CM560), “Protein
Structure”, September 2014, Clarkson University, Potsdam, NY.
11. A. G. Ngounou Wetie, I. Sokolowska, U. Roy, A. G. Woods, and C. C. Darie, Mass
Spectrometry Analysis of NXS/T Glycosylation Sites in Recombinant Glycoproteins -
Poster presented at i) 62nd
ASMS Conference on Mass Spectrometry and Allied Topics,
June 16, 2014, Baltimore Convention Center, Baltimore, MD.; ii) The 10th
Annual
Protein and Antibody Engineering Summit (PEGS), May 2014, Boston, MA.; iii)
Graduate Student Symposium, May 20, 2014, SUNY Buffalo, Buffalo, NY.; iv) NNY
ACS Meeting - Fifth Annual Undergraduate and Graduate Chemistry & Biology
Research Symposium, April 26, 2014, SUNY Plattsburgh, Plattsburgh, NY.
10. U. Roy, A. G. Woods, C. C. Darie, Molecular Dynamics Simulation of Tumor
Differentiation Factor Peptide (TDF-P1), Poster presented at CAMP Annual Technical
Meeting, May 15 2014, Saratoga Springs, NY.
9. K. L. Wormwood, A. G. Ngounou Wetie, I. Sokolowska, K. M. Beglinger, J. W.
Mattingly, U. Roy, J. P. Ryan, A. G. Woods, C. C. Darie, Proteomic Investigation of
Sera and Saliva from Children with Autism Spectrum Disorder and Matched Controls,
Poster presented at i) Graduate Student Symposium, May 20, 2014, SUNY Buffalo,
Buffalo, NY.; ii) NNY ACS Meeting - Fifth Annual Undergraduate and Graduate
Chemistry & Biology Research Symposium, April 26, 2014, SUNY Plattsburgh,
Plattsburgh, NY.
6. Urmi Roy CV
6
8. A. G. Ngounou Wetie, I. Sokolowska, U. Roy, A. G. Woods, C.C. Darie, Proteomic
Investigation of the Tumor Differentiation Factor (TDF)-induced Cell Differentiation,
Poster presented at The 2nd Annual School of Arts & Science Graduate Student
Symposium, December 6th, 2013, Clarkson University, Potsdam, NY.
7. Guest Lecturer for Biochemistry course (BY450/BY650/CM460/CM560), “3D Protein
Structure”, September 2013, Clarkson University, Potsdam, NY.
6. K. L. Wormwood, A. G. Ngounou Wetie, I. Sokolowska, K. M. Beglinger, J. W.
Mattingly, U. Roy, J. P. Ryan, A. G. Woods, C. C. Darie, Proteomic Investigation of Sera
and Saliva from Children with Autism Spectrum Disorder and Matched Controls, - Poster
presented at i) 16th Annual SURE, August 1, 2013, Clarkson University, NY.; ii) The
2013 Smith-Lemli-Opitz Family and Medical Conference, June, 2013, Pittsburgh, PA.;
iii) 61ST ASMS Conference on Mass Spectrometry and Allied Topics, June 13, 2013,
Minneapolis Convention Center, Minneapolis, Minnesota.; iv) NNY ACS Meeting, April
20, 2013, Saint Lawrence University, Canton, NY.; v) 15th Annual SURE, April 13,
2013, Clarkson University, NY.
5. K. M. Beglinger, A. G. Ngounou Wetie, I. Sokolowska, K. L. Wormwood, J. W.
Mattingly, U. Roy, J. P. Ryan, A. G. Woods and C. C. Darie, Proteomic investigation of
saliva from children with Autism Spectrum Disorder (ASD) and matched controls during
circadian rhythmicity, - Poster presented at i) The 2013 Smith-Lemli-Opitz Family and
Medical Conference, June, 2013, Pittsburgh, PA.; ii) 61ST ASMS Conference on Mass
Spectrometry and Allied Topics, June 13, 2013, Minneapolis Convention Center,
Minneapolis, Minnesota.; iii) NNY ACS Meeting, April 20, 2013, Saint Lawrence
University, Canton, NY.; iv) 15th Annual SURE, April 13, 2013, Clarkson University,
NY.
4. A. G. Ngounou Wetie, I. Sokolowska, P. Yang; U. Roy, A. G. Woods, C.C. Darie,
Proteomic Investigation of the Tumor Differentiation Factor (TDF)-induced Cell
Differentiation, Poster presented at 61ST ASMS Conference on Mass Spectrometry and
Allied Topics, June 10, 2013, Minneapolis Convention Center, Minneapolis, Minnesota.
3. I. Sokolowska, A. G. Ngounou Wetie, U. Roy, C. Talbot A. G. Woods, and C. C.
Darie, Mass Spectrometry Analysis of NXS/T Glycosylation Sites in Recombinant
Glycoproteins, Poster presented at 61ST ASMS Conference on Mass Spectrometry and
Allied Topics, June 11, 2013, Minneapolis Convention Center, Minneapolis, Minnesota.
2. U. Roy, Basic Web Design, Talk presented: International Research Experiences for
Students- Advanced Materials for a Sustainable Development (IRES-AMSD) Summer
Students, May 2013, Clarkson University, Potsdam NY.
1. U. Roy, I. Sokolowska, A. G. Woods and C. C. Darie, Structural Investigation of
Tumor Differentiation Factor (TDF) and its Receptor (TDF-R), Poster presented at
CAMP Annual Technical Meeting, May 16 2013, Saratoga Springs, NY.
7. Urmi Roy CV
7
Review Service
Reviewer for American Chemical Society
Computer Skill
• Operating systems: UNIX, Linux, Windows 10/9x/me/XP/7
• Languages: Java, C++ (some), HTML, PHP, JavaScript, Visual Basic
• Database Systems: MS Access, SQL (some)
• Applications Software: Microsoft Office, Corel Draw, Adobe Photo Deluxe,
Dreamweaver, Flash, Fireworks, Origin
• Biological Modeling Package: Accelrys Discovery Studio 3.5 and 3.1; Accelrys
Materials Studio 6; Biosym/Insight II; Molecular Operating Environment (MOE);
Rasmol; Rastop; Pymol; Swiss PDB Viewer (Deepview); Protein Explorer;
Chime; Jmol; UCSF Chimera.
Recent Web Designs and Web Maintenance works
• Center for Advanced Materials Processing, Clarkson University
• Department of Chemistry & Biomolecular Science, Clarkson University
• The Shipley Center for Innovation, Clarkson University
• International Research Experiences for Students: Advanced Materials for a
Sustainable Development
Demonstrated “Web-design” Workshop for “IRES-AMSD” Summer REU
Students, Clarkson University, Potsdam, NY (May 2011, May 2012 and May
2013)
• Clarkson Club
• 79th ACS Colloid and Surface Science Symposium:
• Center for Quantum Device Technology Conference
• Numerous personal websites (mostly for various faculty members at Clarkson
University)
Community Service
• Volunteer for American Cancer Society Spring Daffodil Sale: 2000-2006
• Volunteer for Potsdam Chamber of Commerce Ives Park Planting Project: 2000
• Volunteer for American Red Cross Blood Drive: 2000
• Plant Sale Volunteer for Potsdam Humane Society: 2003
• Clarkson Club Web Designer: 2000-2007
• Volunteer Work for Haiti Relief Fund Function, Potsdam, NY: 2010